Cardiomyopathy Panel

Genes

Selected genes

Test Guide

Exome Panel on Demand (Cardiomyopathy Panel) Test Link

Cardiomyopathy exome panel testing includes genes that have been identified to be responsible for disorders in which cardiomyopathy is a noted feature.  The disease phenotypes include primary myopathies, muscular dystrophies; metabolic storage diseases, Noonan syndrome and cardiofaciocutaneous syndromes among others.  Cardiomyopathy exome panel testing is the most cost-efficient and precise approach to diagnostic testing as there is overlap between phenotypes and the lack of characteristic “other” features in many instances.  Study of the panel genes from the DNA of a single individual allows us to focus on variants reported as pathogenic in the past, on those with a very low population frequency, with nucleotide conservation across species and with likely pathogenic consequence. When variants of unknown significance are identified by panel testing, DNA is requested from first degree relatives to interrogate the significance of the variant. There is no charge for added studies used to aid in interpretation of a sequence change found in the index case.

 

Methodology

 

For current methodology, please go to the Exome Panel on Demand (Cardiomyopathy Panel) Test Link

 

Specimen Requirements

For current specimen requirements, please go to the Exome Panel on Demand (Cardiomyopathy Panel) Test Link

 

How to Order

To order testing, please go to the Exome Panel on Demand (Cardiomyopathy Panel) Test Link

 

CPT Code & Cost

The cost of exome sequencing through the NCGL ranges from $900 to $5000.  To receive the most accurate pricing, please contact the Genetics Pre-Authorization Billing group (gpab@uw.edu).

81439
$Contact lab

© 2025 UW Medicine Laboratory For Precision Diagnostics. All rights reserved.
University of Washington, UW Medicine Pathology.